B | 95% CI | p | |
---|---|---|---|
Cognitive failures | |||
No DNCR (vs. DNCR) | − 0.41 | − 0.80; − 0.02 | 0.038 |
Depression (PHQ-9, per point increase) | 0.13 | 0.09; 0.18 | < 0.001 |
SF-36 physical component score | |||
No DNCR (vs. DNCR) | 0.08 | − 0.02; 0.19 | 0.118 |
Depression (PHQ9, per point increase) | 0.02 | 0.01; 0.03 | 0.001 |
Age (per year increase) | 0.01 | 0.01; 0.02 | 0.001 |
Tumor volume (per ml increase) | 0.01 | 0.00; 0.01 | 0.005 |
No ADT (vs. ADT) | − 0.23 | − 0.42; − 0.05 | 0.014 |
SF-36 mental component score | |||
No DNCR (vs. DNCR) | − 0.04 | − 0.15; 0.06 | 0.417 |
ASA I (vs. ASA III) | − 0.03 | − 0.18; 0.12 | 0.712 |
ASA II (vs. ASA III) | 0.05 | − 0.08; 0.17 | 0.477 |
Depression (PHQ-9, per point increase) | 0.06 | 0.05; 0.07 | < 0.001 |
Age (per year increase) | − 0.00 | − 0.01; 0.00 | 0.464 |
Tumor volume (per ml increase) | 0.01 | 0.00; 0.01 | 0.044 |